Colon Cancer
Recent findings in colon cancer provide new insights
Published in Gastroenterology Week, November 14th, 2005
Study 1: Imaging studies assess angiogenic suppression after SU11248 induction.
Researchers in Italy conducted a study "to compare two dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) techniques in terms of their ability in assessing the early antiangiogenic effect of SU11248, a novel selective multitargeted tyrosine kinase inhibitor, that exhibits direct antitumor and antiangiogenic activity via inhibition of the receptor tyrosine kinases platelet-derived growth factor receptor, vascular endothelial growth factor receptor, KIT and FLT3."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- Cancer Risk Factors
Patients with gallstones develop gallbladder cancer at an earlier age - Gastroesophageal Reflux
"Silent" nighttime acid reflux symptoms can cause poor sleep and sleep apnea - Irritable Bowel Syndrome
Tegaserod improves work and daily activity in IBS patients with constipation - Surgical Techniques
Trends in ablative techniques for Barrett esophagus are investigated - Adverse Drug Reaction
Tysabri safety evaluation complete; no new confirmed cases of PML - Allergy & Immunology
Hepatitis C virus therapy alters the efforts of natural killer T cells - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
